Depression, AnxietyNCT04604080
Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan
An observational study of Depression, Anxiety, run by Islamia University of Bahawalpur at 5 sites in Pakistan.
Trial summary
To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Depression, Anxiety
- What is being tested?
- service of questionnaire
- How many people
- 390 participants
- Where
- 5 sitesPakistan
- Study dates
- 1 Nov 2020to 18 Nov 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Residents/ Visitors of the south punjab will be the study population of this study
Who may be able to join
None listed.
Who cannot join
- Unconcious and non-cooperative individuals
- -
Trial locations and contacts
5 sites in 1 country.
5 sites in 1 country
Pakistan5 sites
The Islamia University of Bahawalpur
Chak Eighty-seven -Twelve Left, Punjab Province, 63100
GC University Faisalabad
Faisalabad, Punjab Province, 37150
Quaid-i-Azam University Islamabad
Islamabad, 45320
University of Veterinary and Animal Sciences, Lahore
Lahore, Punjab Province, 54000
Bahauddin Zakriya University Multan
Multan, Punjab Province, 60800
About this study
To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings.
Read the detailed description
This study is designed to assess the prevalence of depression after the general and smart lockdown in various areas. This study includes both genders of any age.
- Conditions
- Depression, Anxiety
- Being tested
- service of questionnaire
- Keywords
- Depression, Anxiety, Epidemiology
- Medical subject headings
- Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
service of questionnaireOther
Respondents will be given a survey form only and after filling this will be collected back
| Study group | Role | What they receive |
|---|---|---|
| single group | Respondents will be given survey form, filled and will be collected back Receives: Other: service of questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence estimation of depression in adults
% prevalence of depression in adult population of south punjab will be assessed
Measured: study will be completed in 15 days maximum
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Oct 2020
- Study start1 Nov 2020
- Primary completion18 Nov 2020
- Study completion18 Nov 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Depression, AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 390 participants (actual)
Sponsor and investigators
- Lead sponsor
- Islamia University of Bahawalpur
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jafir Hussain Shirazi, Islamia University of Bahawalpur
- Investigators
- Jafir Shirazi, PhD, Principal investigator, The Islamia University of Bahawalpur
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04604080
- Sponsor's protocol ID
- U1111-1260-1614
- Status last verified
- Nov 2020
- First submitted
- 25 Oct 2020
- Last updated
- 19 Nov 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan
- ClinicalTrials.gov ID
- NCT04604080
- Acronym / sponsor ID
- U1111-1260-1614
- Conditions
- Depression, Anxiety
- Keywords
- Depression, Anxiety, Epidemiology
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 390 participants (actual)
- Lead sponsor
- Islamia University of BahawalpurUniversity, hospital or other
- Study start
- 1 Nov 2020 (actual)
- Primary completion
- 18 Nov 2020 (actual)
- Study completion
- 18 Nov 2020 (actual)
- First posted
- 27 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To assess the depression in adults especially in post COVID-19 duration in the rural and urban settings.
Detailed description
This study is designed to assess the prevalence of depression after the general and smart lockdown in various areas. This study includes both genders of any age.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| single group | – | Other: service of questionnaireRespondents will be given survey form, filled and will be collected back |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Residents/ Visitors of the south punjab will be the study population of this study
Key inclusion criteria (0 listed)
Key exclusion criteria (2 listed)
- Unconcious and non-cooperative individuals
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| service of questionnaireRespondents will be given a survey form only and after filling this will be collected back | Other | single group |
Primary outcome
Prevalence estimation of depression in adults
Time frame: study will be completed in 15 days maximum
% prevalence of depression in adult population of south punjab will be assessed
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Nov 2020.
- Individual participant dataSharing planned: No
Related trials for Depression, Anxiety
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jafir Shirazi, PhD principal investigator
The Islamia University of Bahawalpur
5 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Depression, Anxiety, run by Islamia University of Bahawalpur at 5 sites in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence estimation of depression in adults (time frame: study will be completed in 15 days maximum). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2020.